Funding Opportunity RFA-CA-21-054 from the NIH Guide for Grants and Contracts. The TBEL program aims to integrate basic and translational cancer research concepts to examine the direct causal relationships and interactions of an early lesion, its microenvironment and host-systemic factors as co-organizers of tumor initiation (or suppression) and malignant progression. The ultimate goals of the TBEL program are to further understand the biological and pathophysiological mechanisms driving or restraining precancers and early cancers and facilitate biology-backed precision prevention approaches. The FOA will utilize the U54 (Specialized Center--Cooperative Agreements) activity code. Each TBEL Center shall have a unique thematic focus and be structured to test hypotheses that bridge basic and translational research in a synergistic and iterative fashion. Collectively, TBEL Centers will operate as a network that will inform future, rationally-design modes of intervention that are founded on strong biological mechanisms and be comprehensive, multi-dimensional, and appropriately tailored to the degree of malignant potential of an early lesion.

Funding Opportunity RFA-CA-21-055 from the NIH Guide for Grants and Contracts. The TBEL program aims to integrate basic and translational cancer research concepts to examine the direct causal relationships and interactions of an early lesion, its microenvironment, and host-systemic factors as co-organizers of tumor initiation (or suppression) and malignant progression. The ultimate goals of the TBEL program are to further understand the biological and pathophysiological mechanisms driving or restraining precancers and early cancers and facilitate biology-backed precision prevention approaches. The responsibilities of the CDMC will be to (1) coordinate consortium-wide meetings and conferences, and cross-consortium collaborative activities; (2) provide statistical and computational analysis support; and (3) establish program data hub for data capture, curation and management, and protocol development and registration. The other scientific unit of the TBEL program will comprise the U54 Centers, which will be structured to efficiently bridge gaps between basic and translational research on early lesions and their microenvironments. This Notice is being provided to allow potential applicants sufficient time to develop a responsive TBEL Coordinating and Data Management Center application. The FOA is expected to be published in May 2021 with an anticipated application due date in October 2021. Details of the planned pre-application webinar will be announced in the Guide after publication of the FOA. The companion notice for the TBEL U54 Centers is: NOT-CA-21-XXX. The FOA will not be restricted to specific early lesion/cancer type(s).

Notice NOT-HL-21-029 from the NIH Guide for Grants and Contracts

Notice NOT-OH-21-011 from the NIH Guide for Grants and Contracts

Our Experimental Error columnist remembers a key figure from grad school

Notice NOT-AG-21-060 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-340 from the NIH Guide for Grants and Contracts

Notice NOT-EB-21-020 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-020 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-015 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-027 from the NIH Guide for Grants and Contracts

Notice NOT-OH-21-012 from the NIH Guide for Grants and Contracts

$200000 -$210000: Telethon Kids Institute: The Opportunity  Here at Telethon Kids Institute we bring together the best minds and pursue the most promising science. We have a passion to see o... Nedlands (Suburb), Perth (AU)

Notice NOT-NR-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-059 from the NIH Guide for Grants and Contracts

£70-75 per hour Ltd: CK Group: CK Group are recruiting for a Senior Statistician to join a company in the Pharmaceutical industry, working remotely on a contract basis initially for 12... Cambridge

Competitive Salary: F. Hoffmann-La Roche AG: In Roche’s Pharmaceutical Research and Early Development organisation (pRED), we make transformative medicines for patients in order to tackle some o Switzerland (CH)

Notice NOT-HG-21-038 from the NIH Guide for Grants and Contracts

Notice NOT-ES-21-012 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-279 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients.